A Comprehensive research study conducted by KD Market Research on Surgical Sealants and Adhesives Market Opportunity Analysis and Industry forecast. report offers extensive and highly detailed historical, current and future market trends in Surgical Sealants and Adhesives Market . Surgical Sealants and Adhesives Market report includes market size, growth drivers, barriers, opportunities, trends and other information which helps to find new opportunities in this market for the growth of the business through new technologies and developments.
The global surgical sealants and adhesives market was valued at $1,993 million in 2016, and is expected to reach $3,794 million by 2023, registering a CAGR of 9.7% from 2017 to 2023. Surgical sealants and adhesives are preferred over traditional closure methods such as wires, sutures, and staples, as these techniques create immediate and proper sealing. Surgical sealants and adhesives are expected to replace sutures and staples, owing to their improved closure capabilities, less blood loss, higher implementation rate facilitating less painful operation. Moreover, they are applicable in various surgeries such as central nervous system, general surgery, cardiovascular, pulmonary, ophthalmology, orthopedic, urology, and other surgeries.
Request For sample Copy of this Report @ https://www.kdmarketresearch.com/sample/3380
Urgent need to minimize blood loss in patients and increase in cases of surgical procedures occurring across different countries are the key factors driving the growth of the surgical sealants and adhesives market. Furthermore, surge in adoption of technological advanced products along with certification by regulatory authorities is expected to boost the market growth. However, improper reimbursements in case of surgical adhesive and high costs along with huge data requirements for clinical study designing & launching new products are the factors that hamper the growth of the market. On the contrary, upsurge in demand for surgical sealants & adhesives across the emerging nations is anticipated to offer lucrative growth opportunities for the market.
The global surgical sealants and adhesives market is segmented based on product, indication, application, and region. On the basis of product, the market is bifurcated into natural/biological sealants & adhesives and synthetic & semisynthetic sealants and adhesives. Natural/biological sealants and adhesives are further segmented into by type and by origin. By type, natural/biological sealants and adhesives are classed into polypeptide/protein-based sealants & adhesives and polysaccharide-based sealants & adhesives. Polypeptide/protein-based sealants and adhesives are subsegmented into fibrin based, collagen based, based, and albumin based. Polysaccharide-based sealants and adhesives are further classified into chitosan based and other polysaccharide based. By origin, natural/biological sealants and adhesives are divided into animal based, human based, and plant based. Synthetic & semisynthetic sealants and adhesives are further segmented into cyanoacrylates, polyethylene glycol-based hydrogel, urethane-based adhesives, and other synthetic sealants and adhesives. The market based on indication is fragmented into tissue sealing & hemostasis and tissue engineering. The applications covered in the study include central nervous system (CNS) surgeries, general surgeries, cardiovascular surgeries, orthopedic surgeries, cosmetic surgeries, ophthalmic surgeries, urological surgeries, pulmonary surgeries, and others. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
KEY MARKET BENEFITS FOR STAKEHOLDERS
-This report offers a detailed quantitative analysis of the current trends and future estimations from 2016 to 2023 to identify the prevailing opportunities.
-The market estimations provided in this report are based on comprehensive analysis of the key developments in the industry.
-In-depth analysis based on geography facilitates in analyzing the regional market to assist in strategic business planning.
-The development strategies adopted by key manufacturers are enlisted in the report to understand the competitive scenario of the market.
KEY MARKET SEGMENTS
By Product
-Natural/Biological Sealants and Adhesives
By Type
-Polypeptide/Protein-based Sealants and Adhesives
-Fibrin Based
-Collagen Based
-Gelatin Based
-Albumin Based
-Polysaccharide-based Sealants and Adhesives
-Chitosan Based
-Other Polysaccharide Based
By Origin
-Human Blood Based
-Animal Based
-Plant Based
Synthetic and Semisynthetic Sealants and Adhesives
-Cyanoacrylates
-Polyethylene Glycol-based Hydrogel
-Urethane-based Adhesives
-Other Synthetic Sealants and Adhesives
By Indication
-Tissue Sealing and Hemostasis
-Tissue Engineering
By Application
-Central Nervous System (CNS) Surgeries
-General Surgeries
-Cardiovascular Surgeries
-Orthopedic Surgeries
-Cosmetic Surgeries
-Ophthalmic Surgeries
-Urological Surgeries
-Pulmonary Surgeries
-Others
By Region
-North America
-U.S.
-Canada
-Mexico
-Europe
-Germany
-France
-UK
-Italy
-Spain
-Rest of Europe
-Asia-Pacific
-Japan
-China
-Australia
-India
-South Korea
-Rest of Asia-Pacific
-LAMEA
-Brazil
-Saudi Arabia
-Republic of South Africa
-Rest of LAMEA
KEY PLAYERS PROFILED
-Baxter International Inc.
-B. Braun Melsungen AG
-Cohera Medical, Inc.
-CryoLife Inc.
-C.R. Bard Inc.
-CSL Limited (CSL Behring)
-Johnson & Johnson (Ethicon, Inc.)
-Ocular Therapeutix Inc.
-Sanofi
-Sealantis Ltd.
Browse Complete Research Report with toc@ https://www.kdmarketresearch.com/report/3380/surgical-sealants-and-adhesives-market-amr
Table of Content
CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.2.3. Top winning strategies, by year, 2015-2018*
3.2.4. Top winning strategies, by development, 2015-2018* (%)
3.2.5. Top winning strategies, by company, 2015-2018*
3.3. Porters five forces analysis
3.4. Top player positioning, 2016
3.5. Market dynamics
3.5.1. Drivers
3.5.1.1. Increase in ageing population and rise in awareness towards surgical sealants and adhesives
3.5.1.2. Surge in prevalence of chronic diseases and rise in surgical procedures conducted globally
3.5.1.3. Surge in adoption of technologically advanced products
3.5.2. Restraints
3.5.2.1. High cost and extensive clinical data required for the launch of new surgical sealants and adhesives
3.5.2.2. Popularity of minimally invasive surgeries
3.5.3. Opportunity
3.5.3.1. Introduction of novel surgical sealants and adhesives and rise in healthcare spending
CHAPTER 4: SURGICAL SEALANTS AND ADHESIVES MARKET, BY PRODUCT
4.1. Overview
4.2. Market size and forecast
4.3. Natural/biological surgical sealants and adhesives
4.3.1. Key market trends and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Natural/biological sealants and adhesives, by type
4.3.3.1. Market size and forecast
4.3.3.2. Polypeptide/protein-based sealants and adhesives
4.3.3.2.1. Market size and forecast
4.3.3.2.2. Fibrin based
4.3.3.2.2.1. Market size and forecast
4.3.3.2.3. Collagen based
4.3.3.2.3.1. Market size and forecast
4.3.3.2.4. Gelatin based
4.3.3.2.4.1. Market size and forecast
4.3.3.2.5. Albumin based
4.3.3.2.5.1. Market size and forecast
4.3.3.3. Polysaccharide-based sealants and adhesives
4.3.3.3.1. Market size and forecast
4.3.3.3.2. Chitosan based
4.3.3.3.2.1. Market size and forecast
4.3.3.3.3. Other polysaccharide based
4.3.3.3.3.1. Market size and forecast
4.3.4. Natural/biological sealants and adhesives, by origin
4.3.4.1. Market size and forecast
4.3.4.2. Human blood based
4.3.4.2.1. Market size and forecast
4.3.4.3. Animal based
4.3.4.3.1. Market size and forecast
4.3.4.4. Plant based
4.3.4.4.1. Market size and forecast
4.4. Synthetic & semisynthetic sealants and adhesives
4.4.1. Key market trends and opportunities
4.4.2. Market size and forecast
4.4.3. Market size and forecast
4.4.4. Cyanoacrylates
4.4.4.1. Market size and forecast
4.4.5. Polyethylene glycol-based hydrogel
4.4.5.1. Market size and forecast
4.4.6. Urethane-based adhesives
4.4.6.1. Market size and forecast
4.4.7. Other synthetic sealants and adhesives
4.4.7.1. Market size and forecast
CHAPTER 5: SURGICAL SEALANTS AND ADHESIVES MARKET, BY APPLICATION
5.1. Overview
5.1.1. Market size and forecast
5.2. Central nervous system (CNS) surgeries
5.2.1. Market size and forecast, by region
5.3. General surgeries
5.3.1. Market size and forecast, by region
5.4. Cardiovascular surgeries
5.4.1. Market size and forecast, by region
5.5. Orthopedic surgeries
5.5.1. Market size and forecast, by region
5.6. Cosmetic surgeries
5.6.1. Market size and forecast, by region
5.7. Ophthalmic surgeries
5.7.1. Market size and forecast, by region
5.8. Urological surgeries
5.8.1. Market size and forecast, by region
5.9. Pulmonary surgeries
5.9.1. Market size and forecast, by region
5.10. Others
5.10.1. Market size and forecast, by region
CHAPTER 6: SURGICAL SEALANTS AND ADHESIVES MARKET, BY INDICATION
6.1. Overview
6.1.1. Market size and forecast
6.2. Tissue sealing & hemostasis
6.2.1. Market size and forecast, by region
6.3. Tissue engineering
6.3.1. Market size and forecast, by region
CHAPTER 7: SURGICAL SEALANTS AND ADHESIVES MARKET, BY REGION
7.1. Overview
7.1.1. Market size and forecast
7.2. North America
7.2.1. Key market trends and opportunities
7.2.2. Market size and forecast, by product
7.2.3. Market size and forecast, by indication
7.2.4. Market size and forecast, by application
7.2.5. Market size and forecast, by country
7.2.5.1. U.S. market size and forecast
7.2.5.2. Canada market size and forecast
7.2.5.3. Mexico market size and forecast
7.3. Europe
7.3.1. Key market trends and opportunities
7.3.2. Market size and forecast, by product
7.3.3. Market size and forecast, by indication
7.3.4. Market size and forecast, by application
7.3.5. Market size and forecast, by country
7.3.5.1. Germany market size and forecast
7.3.5.2. UK market size and forecast
7.3.5.3. France market size and forecast
7.3.5.4. Italy market size and forecast
7.3.5.5. Spain market size and forecast
7.3.5.6. Rest of Europe market size and forecast
7.4. Asia-Pacific
7.4.1. Key market trends and opportunities
7.4.2. Market size and forecast, by product
7.4.3. Market size and forecast, by indication
7.4.4. Market size and forecast, by application
7.4.5. Market size and forecast, by country
7.4.5.1. Japan market size and forecast
7.4.5.2. China market size and forecast
7.4.5.3. India market size and forecast
7.4.5.4. Australia market size and forecast
7.4.5.5. South Korea market size and forecast
7.4.5.6. Rest of Asia-Pacific market size and forecast
7.5. LAMEA
7.5.1. Key market trends and opportunities
7.5.2. Market size and forecast, by product
7.5.3. Market size and forecast, by indication
7.5.4. Market size and forecast, by application
7.5.5. Market size and forecast, by country
7.5.5.1. Brazil market size and forecast
7.5.5.2. South Africa market size and forecast
7.5.5.3. Saudi Arabia market size and forecast
7.5.5.4. Rest of LAMEA market size and forecast
CHAPTER 8: COMPANY PROFILES
8.1. Baxter International Inc.
8.1.1. Company overview
8.1.2. Company snapshot
8.1.3. Operating business segments
8.1.4. Product portfolio
8.1.5. Business performance
8.1.6. Key strategic moves and developments
8.2. B. Braun Melsungen AG
8.2.1. Company overview
8.2.2. Company snapshot
8.2.3. Operating business segments
8.2.4. Product portfolio
8.2.5. Business performance
8.3. Cohera Medical, Inc.
8.3.1. Company overview
8.3.2. Company snapshot
8.3.3. Product portfolio
8.3.4. Key strategic moves and developments
8.4. CryoLife Inc.
8.4.1. Company overview
8.4.2. Company snapshot
8.4.3. Operating business segments
8.4.4. Product portfolio
8.4.5. Business performance
8.4.6. Key strategic moves and developments
8.5. C.R. Bard Inc.
8.5.1. Company overview
8.5.2. Company snapshot
8.5.3. Operating business segments
8.5.4. Product portfolio
8.5.5. Business performance
8.6. CSL Limited (CSL Behring)
8.6.1. Company overview
8.6.2. Company snapshot
8.6.3. Operating business segments
8.6.4. Product portfolio
8.6.5. Business performance
8.7. Johnson & Johnson (Ethicon, Inc.)
8.7.1. Company overview
8.7.2. Company snapshot
8.7.3. Operating business segments
8.7.4. Product portfolio
8.7.5. Business performance
8.7.6. Key strategic moves and developments
8.8. Ocular Therapeutix Inc.
8.8.1. Company overview
8.8.2. Company snapshot
8.8.3. Product portfolio
8.8.4. Business performance
8.9. Sanofi
8.9.1. Company overview
8.9.2. Company snapshot
8.9.3. Operating business segments
8.9.4. Product portfolio
8.9.5. Business performance
8.10. Sealantis Ltd.
8.10.1. Company overview
8.10.2. Company snapshot
8.10.3. Operating business segments
8.10.4. Product portfolio
8.10.5. Key strategic moves and developments
Request Exclusive Discount on this Report@ https://www.kdmarketresearch.com/discount/3380
About Us:
KD Market Research is one of the best market research organization that provides B2B research on the growth opportunities of the industry which is the prime factor of the overall revenue of the organization. We identify the pain points which our client is facing around revenue methods and provide them with a comprehensive database which helps them to make intelligent decisions that could ensure growth to the organization.
Our Services include market intelligence, competitive intelligence, and customized research. These research reports help the organizations to make quick and powerful decisions that make out highest growth in revenue.
Contact us -
KD Market Research
150 State Street, Albany,
New York, USA 12207
Website: www.kdmarketresearch.com
Email id- sales@kdmarketresearch.com
More - https://kdmarketresearch.blogspot.com/
The global surgical sealants and adhesives market was valued at $1,993 million in 2016, and is expected to reach $3,794 million by 2023, registering a CAGR of 9.7% from 2017 to 2023. Surgical sealants and adhesives are preferred over traditional closure methods such as wires, sutures, and staples, as these techniques create immediate and proper sealing. Surgical sealants and adhesives are expected to replace sutures and staples, owing to their improved closure capabilities, less blood loss, higher implementation rate facilitating less painful operation. Moreover, they are applicable in various surgeries such as central nervous system, general surgery, cardiovascular, pulmonary, ophthalmology, orthopedic, urology, and other surgeries.
Request For sample Copy of this Report @ https://www.kdmarketresearch.com/sample/3380
Urgent need to minimize blood loss in patients and increase in cases of surgical procedures occurring across different countries are the key factors driving the growth of the surgical sealants and adhesives market. Furthermore, surge in adoption of technological advanced products along with certification by regulatory authorities is expected to boost the market growth. However, improper reimbursements in case of surgical adhesive and high costs along with huge data requirements for clinical study designing & launching new products are the factors that hamper the growth of the market. On the contrary, upsurge in demand for surgical sealants & adhesives across the emerging nations is anticipated to offer lucrative growth opportunities for the market.
The global surgical sealants and adhesives market is segmented based on product, indication, application, and region. On the basis of product, the market is bifurcated into natural/biological sealants & adhesives and synthetic & semisynthetic sealants and adhesives. Natural/biological sealants and adhesives are further segmented into by type and by origin. By type, natural/biological sealants and adhesives are classed into polypeptide/protein-based sealants & adhesives and polysaccharide-based sealants & adhesives. Polypeptide/protein-based sealants and adhesives are subsegmented into fibrin based, collagen based, based, and albumin based. Polysaccharide-based sealants and adhesives are further classified into chitosan based and other polysaccharide based. By origin, natural/biological sealants and adhesives are divided into animal based, human based, and plant based. Synthetic & semisynthetic sealants and adhesives are further segmented into cyanoacrylates, polyethylene glycol-based hydrogel, urethane-based adhesives, and other synthetic sealants and adhesives. The market based on indication is fragmented into tissue sealing & hemostasis and tissue engineering. The applications covered in the study include central nervous system (CNS) surgeries, general surgeries, cardiovascular surgeries, orthopedic surgeries, cosmetic surgeries, ophthalmic surgeries, urological surgeries, pulmonary surgeries, and others. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
KEY MARKET BENEFITS FOR STAKEHOLDERS
-This report offers a detailed quantitative analysis of the current trends and future estimations from 2016 to 2023 to identify the prevailing opportunities.
-The market estimations provided in this report are based on comprehensive analysis of the key developments in the industry.
-In-depth analysis based on geography facilitates in analyzing the regional market to assist in strategic business planning.
-The development strategies adopted by key manufacturers are enlisted in the report to understand the competitive scenario of the market.
KEY MARKET SEGMENTS
By Product
-Natural/Biological Sealants and Adhesives
By Type
-Polypeptide/Protein-based Sealants and Adhesives
-Fibrin Based
-Collagen Based
-Gelatin Based
-Albumin Based
-Polysaccharide-based Sealants and Adhesives
-Chitosan Based
-Other Polysaccharide Based
By Origin
-Human Blood Based
-Animal Based
-Plant Based
Synthetic and Semisynthetic Sealants and Adhesives
-Cyanoacrylates
-Polyethylene Glycol-based Hydrogel
-Urethane-based Adhesives
-Other Synthetic Sealants and Adhesives
By Indication
-Tissue Sealing and Hemostasis
-Tissue Engineering
By Application
-Central Nervous System (CNS) Surgeries
-General Surgeries
-Cardiovascular Surgeries
-Orthopedic Surgeries
-Cosmetic Surgeries
-Ophthalmic Surgeries
-Urological Surgeries
-Pulmonary Surgeries
-Others
By Region
-North America
-U.S.
-Canada
-Mexico
-Europe
-Germany
-France
-UK
-Italy
-Spain
-Rest of Europe
-Asia-Pacific
-Japan
-China
-Australia
-India
-South Korea
-Rest of Asia-Pacific
-LAMEA
-Brazil
-Saudi Arabia
-Republic of South Africa
-Rest of LAMEA
KEY PLAYERS PROFILED
-Baxter International Inc.
-B. Braun Melsungen AG
-Cohera Medical, Inc.
-CryoLife Inc.
-C.R. Bard Inc.
-CSL Limited (CSL Behring)
-Johnson & Johnson (Ethicon, Inc.)
-Ocular Therapeutix Inc.
-Sanofi
-Sealantis Ltd.
Browse Complete Research Report with toc@ https://www.kdmarketresearch.com/report/3380/surgical-sealants-and-adhesives-market-amr
Table of Content
CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.2.3. Top winning strategies, by year, 2015-2018*
3.2.4. Top winning strategies, by development, 2015-2018* (%)
3.2.5. Top winning strategies, by company, 2015-2018*
3.3. Porters five forces analysis
3.4. Top player positioning, 2016
3.5. Market dynamics
3.5.1. Drivers
3.5.1.1. Increase in ageing population and rise in awareness towards surgical sealants and adhesives
3.5.1.2. Surge in prevalence of chronic diseases and rise in surgical procedures conducted globally
3.5.1.3. Surge in adoption of technologically advanced products
3.5.2. Restraints
3.5.2.1. High cost and extensive clinical data required for the launch of new surgical sealants and adhesives
3.5.2.2. Popularity of minimally invasive surgeries
3.5.3. Opportunity
3.5.3.1. Introduction of novel surgical sealants and adhesives and rise in healthcare spending
CHAPTER 4: SURGICAL SEALANTS AND ADHESIVES MARKET, BY PRODUCT
4.1. Overview
4.2. Market size and forecast
4.3. Natural/biological surgical sealants and adhesives
4.3.1. Key market trends and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Natural/biological sealants and adhesives, by type
4.3.3.1. Market size and forecast
4.3.3.2. Polypeptide/protein-based sealants and adhesives
4.3.3.2.1. Market size and forecast
4.3.3.2.2. Fibrin based
4.3.3.2.2.1. Market size and forecast
4.3.3.2.3. Collagen based
4.3.3.2.3.1. Market size and forecast
4.3.3.2.4. Gelatin based
4.3.3.2.4.1. Market size and forecast
4.3.3.2.5. Albumin based
4.3.3.2.5.1. Market size and forecast
4.3.3.3. Polysaccharide-based sealants and adhesives
4.3.3.3.1. Market size and forecast
4.3.3.3.2. Chitosan based
4.3.3.3.2.1. Market size and forecast
4.3.3.3.3. Other polysaccharide based
4.3.3.3.3.1. Market size and forecast
4.3.4. Natural/biological sealants and adhesives, by origin
4.3.4.1. Market size and forecast
4.3.4.2. Human blood based
4.3.4.2.1. Market size and forecast
4.3.4.3. Animal based
4.3.4.3.1. Market size and forecast
4.3.4.4. Plant based
4.3.4.4.1. Market size and forecast
4.4. Synthetic & semisynthetic sealants and adhesives
4.4.1. Key market trends and opportunities
4.4.2. Market size and forecast
4.4.3. Market size and forecast
4.4.4. Cyanoacrylates
4.4.4.1. Market size and forecast
4.4.5. Polyethylene glycol-based hydrogel
4.4.5.1. Market size and forecast
4.4.6. Urethane-based adhesives
4.4.6.1. Market size and forecast
4.4.7. Other synthetic sealants and adhesives
4.4.7.1. Market size and forecast
CHAPTER 5: SURGICAL SEALANTS AND ADHESIVES MARKET, BY APPLICATION
5.1. Overview
5.1.1. Market size and forecast
5.2. Central nervous system (CNS) surgeries
5.2.1. Market size and forecast, by region
5.3. General surgeries
5.3.1. Market size and forecast, by region
5.4. Cardiovascular surgeries
5.4.1. Market size and forecast, by region
5.5. Orthopedic surgeries
5.5.1. Market size and forecast, by region
5.6. Cosmetic surgeries
5.6.1. Market size and forecast, by region
5.7. Ophthalmic surgeries
5.7.1. Market size and forecast, by region
5.8. Urological surgeries
5.8.1. Market size and forecast, by region
5.9. Pulmonary surgeries
5.9.1. Market size and forecast, by region
5.10. Others
5.10.1. Market size and forecast, by region
CHAPTER 6: SURGICAL SEALANTS AND ADHESIVES MARKET, BY INDICATION
6.1. Overview
6.1.1. Market size and forecast
6.2. Tissue sealing & hemostasis
6.2.1. Market size and forecast, by region
6.3. Tissue engineering
6.3.1. Market size and forecast, by region
CHAPTER 7: SURGICAL SEALANTS AND ADHESIVES MARKET, BY REGION
7.1. Overview
7.1.1. Market size and forecast
7.2. North America
7.2.1. Key market trends and opportunities
7.2.2. Market size and forecast, by product
7.2.3. Market size and forecast, by indication
7.2.4. Market size and forecast, by application
7.2.5. Market size and forecast, by country
7.2.5.1. U.S. market size and forecast
7.2.5.2. Canada market size and forecast
7.2.5.3. Mexico market size and forecast
7.3. Europe
7.3.1. Key market trends and opportunities
7.3.2. Market size and forecast, by product
7.3.3. Market size and forecast, by indication
7.3.4. Market size and forecast, by application
7.3.5. Market size and forecast, by country
7.3.5.1. Germany market size and forecast
7.3.5.2. UK market size and forecast
7.3.5.3. France market size and forecast
7.3.5.4. Italy market size and forecast
7.3.5.5. Spain market size and forecast
7.3.5.6. Rest of Europe market size and forecast
7.4. Asia-Pacific
7.4.1. Key market trends and opportunities
7.4.2. Market size and forecast, by product
7.4.3. Market size and forecast, by indication
7.4.4. Market size and forecast, by application
7.4.5. Market size and forecast, by country
7.4.5.1. Japan market size and forecast
7.4.5.2. China market size and forecast
7.4.5.3. India market size and forecast
7.4.5.4. Australia market size and forecast
7.4.5.5. South Korea market size and forecast
7.4.5.6. Rest of Asia-Pacific market size and forecast
7.5. LAMEA
7.5.1. Key market trends and opportunities
7.5.2. Market size and forecast, by product
7.5.3. Market size and forecast, by indication
7.5.4. Market size and forecast, by application
7.5.5. Market size and forecast, by country
7.5.5.1. Brazil market size and forecast
7.5.5.2. South Africa market size and forecast
7.5.5.3. Saudi Arabia market size and forecast
7.5.5.4. Rest of LAMEA market size and forecast
CHAPTER 8: COMPANY PROFILES
8.1. Baxter International Inc.
8.1.1. Company overview
8.1.2. Company snapshot
8.1.3. Operating business segments
8.1.4. Product portfolio
8.1.5. Business performance
8.1.6. Key strategic moves and developments
8.2. B. Braun Melsungen AG
8.2.1. Company overview
8.2.2. Company snapshot
8.2.3. Operating business segments
8.2.4. Product portfolio
8.2.5. Business performance
8.3. Cohera Medical, Inc.
8.3.1. Company overview
8.3.2. Company snapshot
8.3.3. Product portfolio
8.3.4. Key strategic moves and developments
8.4. CryoLife Inc.
8.4.1. Company overview
8.4.2. Company snapshot
8.4.3. Operating business segments
8.4.4. Product portfolio
8.4.5. Business performance
8.4.6. Key strategic moves and developments
8.5. C.R. Bard Inc.
8.5.1. Company overview
8.5.2. Company snapshot
8.5.3. Operating business segments
8.5.4. Product portfolio
8.5.5. Business performance
8.6. CSL Limited (CSL Behring)
8.6.1. Company overview
8.6.2. Company snapshot
8.6.3. Operating business segments
8.6.4. Product portfolio
8.6.5. Business performance
8.7. Johnson & Johnson (Ethicon, Inc.)
8.7.1. Company overview
8.7.2. Company snapshot
8.7.3. Operating business segments
8.7.4. Product portfolio
8.7.5. Business performance
8.7.6. Key strategic moves and developments
8.8. Ocular Therapeutix Inc.
8.8.1. Company overview
8.8.2. Company snapshot
8.8.3. Product portfolio
8.8.4. Business performance
8.9. Sanofi
8.9.1. Company overview
8.9.2. Company snapshot
8.9.3. Operating business segments
8.9.4. Product portfolio
8.9.5. Business performance
8.10. Sealantis Ltd.
8.10.1. Company overview
8.10.2. Company snapshot
8.10.3. Operating business segments
8.10.4. Product portfolio
8.10.5. Key strategic moves and developments
Request Exclusive Discount on this Report@ https://www.kdmarketresearch.com/discount/3380
About Us:
KD Market Research is one of the best market research organization that provides B2B research on the growth opportunities of the industry which is the prime factor of the overall revenue of the organization. We identify the pain points which our client is facing around revenue methods and provide them with a comprehensive database which helps them to make intelligent decisions that could ensure growth to the organization.
Our Services include market intelligence, competitive intelligence, and customized research. These research reports help the organizations to make quick and powerful decisions that make out highest growth in revenue.
Contact us -
KD Market Research
150 State Street, Albany,
New York, USA 12207
Website: www.kdmarketresearch.com
Email id- sales@kdmarketresearch.com
More - https://kdmarketresearch.blogspot.com/
No comments:
Post a Comment